GALT Price Targets and Analyst Ratings NASDAQ:GALT
GALT Forecast. What You Should Know.
GALT Historical Ratings and Targets
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... Read more
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.